Is Axsome Therapeutics Stock Ready to Rebound?

Axsome Therapeutics (NASDAQ: AXSM) has been a beaten-down biotech stock throughout much of this year. In this Motley Fool Live video recorded on Aug. 4, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not there's upside potential for the stock going forward. (Note: This video was recorded before Axsome announced that the U.S. Food and Drug Administration identified issues that delay an approval decision on AXS-05 in treating depression.)

Continue reading

Source Fool.com